DOI: 10.1039/C4OB02383H
Page 5 of 7
Journal Name
Organic & Biomolecular Chemistry
ARTICLE
MeOH in CH2Cl2) and followed by second DCVC on Al2O3 (5%
6-(Imidazo[1,2-
benzo[de]isoquinoline-1,3(2
mL,
a
]pyridin-3-yl)-2-octyl-1
H-
H
)-dione (3d); Compound
1
(0.3 EtOAc in hexanes) to afford off-white solid (159 mg, 32%), mp.
3
mmol), 6-(imidazo[1,2-a]pyridin-3-yl)-2-octyl-1H- 134°C. 1H NMR (500 MHz, CDCl3): δ = 7.99 (d, J = 8.3 Hz, 1
benzo[de]isoquinoline-1,3(2H)-dione 2d (776 mg, 2 mmol), H), 7.95 (d, J = 8.3 Hz, 1 H), 7.75 – 7.67 (m, 4H), 7.61 (dd, J1 =
KOAc (393 mg, 4 mmol). The resulting mixture was purified by 8.3 Hz, J2 = 6.8 Hz, 1 H), 7.56 – 7.52 (m, 2H), 7.46 (m, 1H), 6.75
DCVC
on
Al2O3
(CH2Cl2)
and
recrystallized (m, 1H), 6.46 ppm (td, J1 = 7.3 Hz, J2 = 1 Hz, 1 H); 13C NMR
(cyclohexane/EtOAc) to affords yellow crystals (424 mg, 50%), (126 MHz, CDCl3): δ = 134.0, 131.9, 131.1, 129.8, 128.5, 127.4,
1
mp. 145-147°C. H NMR (500 MHz, CDCl3): δ = 8.71 (d, J = 126.9, 126.9, 126.3, 125.6, 125.3, 121.8, 120.3, 118.8, 118.6,
7.3 Hz, 1 H), 8.67 (dd, J1 = 7.3 Hz, J2 = 1 Hz, 1 H), 8.10 (dd, J1 112.6 ppm; HRMS (ESI): m/z ([M+H]+) calcd. for C17H13N2:
= 8.6 Hz, J2 = 1 Hz, 1 H), 7.93 (dd, J1 = 7.8 Hz, J2 = 1 Hz, 1 H), 245.1075; found: 245.1069.
7.90 (d, J = 7.3 Hz, 1 H), 7.89 (s, 1 H), 7.80 (dt, J1 = 9.3 Hz, J2
General procedure for anion radical coupling (9, 10a-d,
= 1 Hz, 1 H), 7.74 (dd, J1 = 8.3 Hz, J2 = 7.3 Hz, 1 H), 7.32 (ddd, 11a,b); Imidazopyridine derivative (0.1 mmol) was dissolved in
J1 = 9.3 Hz, J2 = 6.9 Hz, J3 = 1 Hz, 1 H), 6.85 (dd, J1 = 6.8 Hz, dry toluene (1.5 mL) under argon atmosphere in a Schlenck
J2 = 1.4 Hz, 1 H), 4.21 (t, J = 7.8, 2 H), 1.76 (m, 2 H), 1.47 – 1.25 flask. Potassium was then added and the mixture was degassed
(m, 10 H), 0.88 ppm (t, J = 7 Hz, 3 H); 13C NMR (126 MHz, backfill with Ar. The reaction mixture then stirred at 95 °C for
CDCl3): δ = 164.1, 163.9, 146.8, 135.4, 133.0, 131.8, 131.7, 30 minutes under Ar flows with condensator attached.
131.0, 130.4, 129.1, 128.7, 127.8, 123.8, 123.5, 123.2, 121., Subsequently air/oxygen in a balloon introduced and stirred at
118.6, 113.4, 40.8, 32.0, 29.5, 29.4, 28.3, 27.9, 22.8, 14.2 ppm; the same temperature for one day, quenched by EtOH under Ar,
HRMS (ESI): m/z ([M+H]+) calcd for C27H28N3O2: 426.2182; and directly absorbed onto celite. Product was purified as
found: 426.2185.
follows:
Imidazo[2,1,5-de]naphtho[1,8-ab]quinolizine (9); Compound
5-(Naphthalen-1-yl)imidazo[1,2-
a
]pyridine (5a); 4,4,5,5-
8 (49.7 mg, 0.2 mmol), K (39 mg, 1 mmol), and toluene (3 mL)
Tetramethyl-2-(naphthalen-1-yl)-1,3,2-dioxaborolane (4a, 400 were reacted under air. Reaction mixture was pre-purified by
mg, 1.56 mmol) and Pd(PPh3)4 (92 mg, 0.08 mmol) were stirred DCVC on SiO2 (1% MeOH in CH2Cl2) followed by column
in DME (6 mL) at rt under Ar. To this mixture compound 2e (307 chromatography on SiO2 (1% TEA and 15% EtOAc in
mg, 1.56 mmol), EtOH (4 mL), and saturated aqueous Na2CO3 cyclohexane) to afford yellowish-red solid (24.8 mg, 52%), mp.
(4 mL) were added subsequently. The mixture were refluxed at 175-179°C. 1H NMR (500 MHz, CDCl3): δ = 7.93 (d, J = 7.3 Hz,
110 °C for 17 h, cooled and extracted with CH2Cl2/saturated 1 H), 7.73 (d, J = 7.3 Hz, 1 H), 7.58 (d, J = 8.2 Hz, 1 H), 7.45 (d,
NaHCO3. The organic fraction were collected and solvent J = 8.1 Hz, 1 H), 7.40 – 7.32 (m, 3 H), 7.20 (d, J = 9.0 Hz, 1 H),
evaporated. The resulting mixture were purified by DCVC on 7.02 (d, J = 7.0 Hz, 1 H), 6.73 ppm (dd, J1 = 9.0 Hz, J2 = 6.9 Hz,
Al2O3 (15% EtOAc in hexanes) to afford white solid (345 mg, 1 H); 13C NMR (126 MHz, CDCl3): δ = 135.9, 135.2, 133.3,
1
90%), mp. 149-150°C. H NMR (500 MHz, CDCl3): δ = 8.04 131.7, 130,0 128.5, 127.6, 126.4, 126.3, 125.8, 122.2, 119.0,
(dd, J1 = 6.4 Hz, J2 = 3.4 Hz, 1 H), 7.97 (d, J = 8.3 Hz, 1 H), 7.74 117.9, 117.2, 107.3 ppm; HRMS (ESI): m/z ([M+H]+) calcd. for
(d, J = 8.8 Hz, 1 H), 7.64 – 7.60 (m, 2 H), 7.56 – 7.53 (m, 2 H), C17H11N2: 243.0922; found: 243.0919.
7.41 (m, 1 H), 7.35 – 7.32 (m, 2 H), 6.98, (s, 1 H) 6.89 ppm (d, J
Anthra[1,9-ab]imidazo[5,1,2-de]quinolizine
(10a);
= 6.8 Hz, 1 H); 13C NMR (126 MHz, CDCl3): δ = 146.1, 137.1, Compound 3a (59 mg, 0.2 mmol), K (78 mg, 2 mmol) were
133.8, 133.5, 131.8, 130.9, 130.5, 128.8, 128.0, 127.3, 126.7, reacted in toluene (3 mL) under air. Purification using DCVC on
125.7, 125.0, 124.5, 117. 1, 114.0, 112.0 ppm; HRMS (EI): m/z SiO2 (1% TEA in CH2Cl2, Et2O) followed by crystallization
(M+) calcd. for C17H12N2: 244.1000; found: 244.0995.
5-(Phenanthren-9-yl)imidazo[1,2-
procedure of 5a, 4,4,5,5-tetramethyl-2-(phenanthren-9-yl)-1,3,2- 1 H), 8.26 (s, 1 H), 7.80 (s, 1 H), 7.78 (d, J = 8.5 Hz, 1 H), 7.59
dioxaborolane 4b (600 mg 1.95 mmol), Pd(PPh3)4 (115 mg, 0.1 – 7.58 (m, 2 H), 7.47 (t, J = 8.1 Hz, 1 H), 7.42 (t, J = 7.6 Hz, 1
(CH2Cl2/cyclohexane) afforded red crystal (6.8 mg, 12%), mp.
a
]pyridine (5b); following 178-180°C. 1H NMR (500 MHz, CDCl3): δ = 8.32 (d, J = 8.1 Hz,
,
mmol), DME (7.5 mL), compound 2e (385 mg, 1.95 mmol), H), 7.35 (t, J = 5.3 Hz, 1 H), 7.22 – 7.18 ppm (m, 3 H); 13C NMR
EtOH (5 mL), and saturated Na2CO3 (5 mL) were reacted. The (126 MHz, CDCl3): δ = 145.9, 136.2, 133.5, 132.7, 132.5, 129.1,
resulting mixture was purified by column chromatography on 129.0, 128.0, 127.4, 126.6, 126.6, 126.0, 125.3, 124.9, 124.7,
SiO2 (2% MeOH in CH2Cl2) and recrystallized (EtOAc) to afford 124.1, 123.2, 121.9, 117.7, 116.2, 106.7 ppm; HRMS (EI): m/z
white crystals (419 mg, 73%), mp. 178.6-179.6°C. 1H NMR (500 (M+) calcd. for C21H12N2: 292.1000; found: 292.1003.
MHz, CDCl3): δ = 8.82 (d, J = 8.3 Hz, 1 H), 8.79 (d, J = 8.3 Hz,
1 H), 7.94 (d, J = 7.8 Hz, 1 H), 7.91 (s, 1 H), 7.80 – 7.67 (m, 4
Imidazo[5,1,2-de]phenanthro[1,10-ab]quinolizine
(10b);
H), 7.54 (d, J = 1.5 Hz, 1 H), 7.48 (ddd, J1 = 8.3 Hz, J2 = 6.8 Hz, Compound 3b (58.9 mg, 0.2 mmol) and K (78 mg, 2 mmol) were
J3 = 1 Hz, 1 H), 7.39 – 7.33 (m, 2 H), 7.01 (s, 1 H), 6.98 ppm reacted in toluene (3 mL) under air. Purification using DCVC on
(dd, J1 = 6.8 Hz, J2 = 1 Hz, 1 H); 13C NMR (126 MHz, CDCl3): SiO2 (2% MeOH in CH2Cl2) followed by crystallization
δ = 146.0, 137.2, 133.6, 131.2, 131.1, 130.8, 130.6, 129.5, 129.3, (CH2Cl2/EtOAc) afforded red crystals (22.6 mg, 38%), mp. 257-
1
129.3, 128.2, 127.5, 127.5, 127.4, 125.9, 124.5, 123., 122.9, 259°C. H NMR (500 MHz, CDCl3): δ = 8.34 (d, J = 8.2 Hz, 1
117.2, 114.0, 112.1 ppm; HRMS (EI): m/z (M+) calcd. for H), 8.32 (d, J = 8.4 Hz, 1 H), 7.91 (s, 1 H), 7.80 (d, J = 7.6 Hz, 1
C21H14N2: 294.1157; found: 294.1147.
H), 7.63 (d, J = 7.6 Hz, 1 H), 7.52 – 7.44 (m, 4 H), 7.36 (d, J =
3-(Naphthalen-1-yl)imidazo[1,5-a]pyridine (8); In a pressure 8.7 Hz, 1 H), 7.17 (d, J = 6.9 Hz, 1 H), 7.11 ppm (dd, J1 = 8.6
reaction tube, Cs2CO3 (0.7 g, 2.2 mmol) was heated at 150 °C Hz, J2 = 7.2 Hz, 1 H); 13C NMR (126 MHz, CDCl3): δ = 145.7,
under Ar flow. Subsequently Pd(OAc)2 (22.4 mg, 5 mol%), PPh3 134.3, 132.3, 132.0, 129.5, 128.1, 127.8, 127. 6, 127.4, 127.0,
(26.4 mg, 5 mol%), imidazo[1,5-a]pyridine (6, 240 mg, 2 mmol), 126.3, 126.1, 125.8, 124.0, 123.1, 122.6, 122.6, 120.4, 116.8,
1-iodonaphthalene (0.32 mL, 2.2 mmol), and DMAc (4 mL) 115.6, 106.8 ppm; HRMS (EI): m/z (M+) calcd. for C21H12N2:
were added under Ar. The vessel was closed and the reaction was 292.1000; found: 292.0993.
stirred at the same temperature for 21 h. The resulting mixture
was absorbed into celite, pre-purified by DCVC on SiO2 (1%
This journal is © The Royal Society of Chemistry 2012
J. Name., 2012, 00, 1-3 | 5